Circulating vitamin D concentration and risk of 14 cancers: a bidirectional Mendelian randomization study
- PMID: 37642723
- PMCID: PMC11796945
- DOI: 10.1007/s00432-023-05322-9
Circulating vitamin D concentration and risk of 14 cancers: a bidirectional Mendelian randomization study
Abstract
Background: Observational studies have revealed relationships between circulating vitamin D concentrations and the risk of different types of cancer, although the potential causal relationship remains controversial. This study aims to investigate the presence of a causal relationship between circulating vitamin D concentrations and the risk of different types of cancer.
Methods: Summary statistics from corresponding genome-wide association studies (GWASs) were used to investigate the causal relationship between circulating vitamin D concentrations and the risk of 14 cancers. A two-sample Mendelian randomization (MR) analysis using inverse-variance weighting (IVW) as the primary method was performed. Additionally, the results were verified using four other methods, including MR-Egger, weighted median, weighted mode, and simple mode. Multiple sensitivity analyses were conducted to ensure the robustness of our MR findings.
Results: The MR analysis showed no causal relationship between circulating vitamin D concentrations and most types of cancer, except for a causal relationship with melanoma skin cancer (MSC) (odds ratio [OR]IVW = 1.003, 95% confidence intervals [CI] 1.001-1.005, P = 0.004). Conversely, reverse MR revealed a causal relationship between circulating vitamin D concentration and colorectal cancer (ORIVW = 0.398, 95% CI 0.195-0.813, P = 0.01; ORweighted median = 0.352, 95% CI 0.135-0.917, P = 0.03).
Conclusions: Our findings provide support for a causal relationship between circulating vitamin D concentration and risk of MSC. Additionally, we found a causal relationship between circulating vitamin D concentration and risk of colorectal cancer in reverse-MR analysis. This evidence indicate that vitamin D is of great significance in the prevention and treatment of MSC and the prognosis of colorectal cancer.
Keywords: Cancer; Colorectal cancer; Melanoma skin cancer; Mendelian randomization; Vitamin D.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
[Multi-omics Mendelian randomization study on the causality between non-ionizing radiation and facial aging].Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025 Jun 20;41(6):594-603. doi: 10.3760/cma.j.cn501225-20240830-00320. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025. PMID: 40588408 Free PMC article. Chinese.
-
Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional Mendelian Randomization Study.World Neurosurg. 2025 Apr;196:123718. doi: 10.1016/j.wneu.2025.123718. Epub 2025 Mar 13. World Neurosurg. 2025. PMID: 39929265
-
Unraveling the causal nexus between serum lactate levels and cancer risk: A Mendelian randomization study.Medicine (Baltimore). 2025 Jul 25;104(30):e43388. doi: 10.1097/MD.0000000000043388. Medicine (Baltimore). 2025. PMID: 40725915 Free PMC article.
-
Effectiveness and safety of vitamin D in relation to bone health.Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
Cited by
-
Genetically proxied risk and protective factors for pancreatic cancer: a systematic review and meta-analysis of Mendelian randomization studies.J Gastrointest Oncol. 2025 Jun 30;16(3):1233-1247. doi: 10.21037/jgo-2025-305. Epub 2025 Jun 27. J Gastrointest Oncol. 2025. PMID: 40672103 Free PMC article.
-
Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling.Cancers (Basel). 2024 Jun 18;16(12):2262. doi: 10.3390/cancers16122262. Cancers (Basel). 2024. PMID: 38927967 Free PMC article. Review.
References
-
- Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ (2007) 1alpha,25-dihydroxyvitamin D3 (calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 6(4):1433–1439. 10.1158/1535-7163.MCT-06-0677 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical